Chemoreflex function in heart failure
1Department of Physiology and Biophysics, University of Nebraska College of Medicine, 984575 Nebraska Medical Center, Omaha, NE 68198-4575, USA. hschultz@unmc.edu
Heart Failure Reviews
|October 18, 2005
Summary
Chemoreflexes regulate breathing and blood pressure. In heart failure, altered chemoreflex function may contribute to sympathetic overactivity and disease progression, impacting cardiovascular health.
Area of Science:
- Cardiovascular Physiology
- Autonomic Nervous System Regulation
- Respiratory Control
Background:
- Peripheral and central chemoreflexes are key autonomic regulators of ventilation and neural circulatory control.
- These reflexes increase sympathetic nerve traffic and blood pressure.
- Chronic heart failure (CHF) involves sustained sympathetic overactivity, a major factor in disease progression.
Purpose of the Study:
- To review the function of peripheral and central chemoreflexes in heart failure.
- To explore potential mechanisms behind altered chemoreflex function in CHF.
- To assess the contribution of chemoreflexes to ventilatory and circulatory abnormalities in heart failure.
Main Methods:
- Literature review of existing evidence on chemoreflex function in heart failure.
- Analysis of studies investigating mechanisms of chemoreflex alteration in CHF.
- Synthesis of data linking chemoreflexes to cardiovascular and respiratory changes in heart failure.
Main Results:
- Evidence documents altered peripheral and central chemoreflex function in heart failure.
- Potential mechanisms for these alterations are discussed.
- Chemoreflex dysfunction is implicated in the pathophysiology of heart failure.
Conclusions:
- Chemoreflexes play a significant role in sympathetic control during heart failure.
- Understanding chemoreflex alterations is crucial for addressing cardiovascular and ventilatory issues in CHF.
- Further research is needed to fully elucidate the role of chemoreflexes in heart failure progression.
Related Concept Videos
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.


